메뉴 건너뛰기




Volumn 80, Issue 6, 2004, Pages 229-232

Preventive medical check-up and early detection of diabetes mellitus type 2 "sane diseased" or "diseased sane";Gesundheitsvorsorge und diabetes-früherkennung "gesund krank" oder "krank gesund" untersuchung zur gesundheitsvorsorge und diabetes-früherkennung

Author keywords

Diabetes mellitus type 2; Family practice; Oral glucose tolerance test; Prediabetic state; Prevention control

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; EARLY DIAGNOSIS; GENERAL PRACTICE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; SCREENING;

EID: 3042772558     PISSN: 09376801     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (2)

References (21)
  • 1
    • 0001882377 scopus 로고
    • The NIDDM epidemic: Global estimates and projections - A look into the crystal ball
    • Zinmet P, McCarty DJ. The NIDDM epidemic: Global estimates and projections - A look into the crystal ball. IDF-bulletin 1995; 40: 8-16
    • (1995) IDF-bulletin , vol.40 , pp. 8-16
    • Zinmet, P.1    McCarty, D.J.2
  • 2
    • 84862383580 scopus 로고    scopus 로고
    • Prädiabetes
    • Hasslacher C. Prädiabetes. MMW 2003; 145: 5-21
    • (2003) MMW , vol.145 , pp. 5-21
    • Hasslacher, C.1
  • 3
    • 0032511120 scopus 로고    scopus 로고
    • Verbreitung des diabetes mellitus in Deutschland
    • Hauner H. Verbreitung des Diabetes mellitus in Deutschland. Deutsche Medizinische Wochenschrift 1998; 123: 777-782
    • (1998) Deutsche Medizinische Wochenschrift , vol.123 , pp. 777-782
    • Hauner, H.1
  • 6
    • 0025367559 scopus 로고
    • Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?
    • Haffner SM, Stern MB. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 1990; 262: 2893-2898
    • (1990) JAMA , vol.262 , pp. 2893-2898
    • Haffner, S.M.1    Stern, M.B.2
  • 7
    • 0033998816 scopus 로고    scopus 로고
    • The impact of diabetes mellitus on survival after myocardial infarction: Can it be modified by drug treatment? Results of a population - Based myocardial infarction register follow-up study
    • Löwel H, Koenig W, Engel S, Hörmann A, Keil U. The impact of diabetes mellitus on survival after myocardial infarction: Can it be modified by drug treatment? Results of a population - based myocardial infarction register follow-up study. Diabetologia 2000; 43: 218-226
    • (2000) Diabetologia , vol.43 , pp. 218-226
    • Löwel, H.1    Koenig, W.2    Engel, S.3    Hörmann, A.4    Keil, U.5
  • 8
    • 0031460261 scopus 로고    scopus 로고
    • Efficacy of 24-weak mono-therapy with Acarbose, Metformin or Placebo in dietary-treated NIDDM-patients: The Essen-II-Study
    • Hoffmann J, Spengler M. Efficacy of 24-weak mono-therapy with Acarbose, Metformin or Placebo in dietary-treated NIDDM-patients: The Essen-II-Study. Am J Met 1997; 103: 483-490
    • (1997) Am J Met , vol.103 , pp. 483-490
    • Hoffmann, J.1    Spengler, M.2
  • 9
    • 0037097039 scopus 로고    scopus 로고
    • Acarbose for prevention of type 2 diabetes mellitus: The STOP-NIDDM randomised trial
    • Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 2002; 359: 2072-2077
    • (2002) Lancet , vol.359 , pp. 2072-2077
    • Chiasson, J.L.1    Josse, R.G.2    Gomis, R.3    Hanefeld, M.4    Karasik, A.5    Laakso, M.6
  • 11
    • 0035799806 scopus 로고    scopus 로고
    • Finnish Diabetes Prevention Study group: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance
    • Tuomilehto J, Lindstrom J, Eriksson JG et al. Finnish Diabetes Prevention Study group: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-1350
    • (2001) N Engl J Med , vol.344 , pp. 1343-1350
    • Tuomilehto, J.1    Lindstrom, J.2    Eriksson, J.G.3
  • 12
    • 0030935652 scopus 로고    scopus 로고
    • Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study
    • Pan XR, Li GW, Hu YH et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997; 20: 537-544
    • (1997) Diabetes Care , vol.20 , pp. 537-544
    • Pan, X.R.1    Li, G.W.2    Hu, Y.H.3
  • 13
    • 0037034257 scopus 로고    scopus 로고
    • Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
    • Knowler WC, Barrett-Connor E, Fowler SE et al. Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403
    • (2002) N Engl J Med , vol.346 , pp. 393-403
    • Knowler, W.C.1    Barrett-Connor, E.2    Fowler, S.E.3
  • 16
    • 84862373908 scopus 로고    scopus 로고
    • Persönliche Mitteilungen des Zentralinstitutes für die kassenärztliche Vereinigung in der Bundesrepublik Deutschland vom 5.9.2003
    • Persönliche Mitteilungen des Zentralinstitutes für die kassenärztliche Vereinigung in der Bundesrepublik Deutschland vom 5.9.2003
  • 17
    • 0033592101 scopus 로고    scopus 로고
    • Glucosetolerance and mortality: Comparison of WHO and american diabetes association diagnostic criterial
    • The Decode-Study Group on behalf of the European diabetes-epidemiology group. Glucosetolerance and mortality: Comparison of WHO and american diabetes association diagnostic criterial. Lancet 1999; 354: 617-621
    • (1999) Lancet , vol.354 , pp. 617-621
  • 18
    • 84862386733 scopus 로고
    • Metabolisches syndrom und makroangiopathie teil I. Bedeutung und diagnostische überlegungen
    • Jacob S, Klimm H-D, Rett K, Augustin HJ, Dietze GJ. Metabolisches Syndrom und Makroangiopathie Teil I. Bedeutung und diagnostische Überlegungen. Perfusion 1995; 8: 339-347
    • (1995) Perfusion , vol.8 , pp. 339-347
    • Jacob, S.1    Klimm, H.-D.2    Rett, K.3    Augustin, H.J.4    Dietze, G.J.5
  • 19
    • 3042734937 scopus 로고
    • Metabolisches syndrom und makroangiopathie teil II. Therapeutische option
    • Jacob S, Klimm H-D, Rett K, Augustin HJ, Dietze GJ. Metabolisches Syndrom und Makroangiopathie Teil II. Therapeutische Option. Perfusion 1995; 8: 360-368
    • (1995) Perfusion , vol.8 , pp. 360-368
    • Jacob, S.1    Klimm, H.-D.2    Rett, K.3    Augustin, H.J.4    Dietze, G.J.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.